Page last updated: 2024-11-05

3-iodobenzoate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

3-iodobenzoate is an aromatic compound that has been investigated for its potential use in various applications, including organic synthesis and materials science. Its synthesis typically involves the iodination of benzoate using iodine and an oxidizing agent. The presence of the iodine atom at the 3-position provides a reactive site for further functionalization, making it a valuable building block for the synthesis of more complex molecules. 3-iodobenzoate has also been explored as a precursor for the preparation of metal-organic frameworks (MOFs) and other materials with interesting properties. The importance of 3-iodobenzoate lies in its versatility and potential for use in different fields. Researchers study this compound to understand its reactivity, explore its applications in organic synthesis and materials science, and develop new methods for its preparation and utilization.'

3-iodobenzoic acid: RN given refers to unlabeled parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

3-iodobenzoic acid : An iodobenzoic acid with a single iodo substituent placed at the 3-position. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID12060
CHEMBL ID67526
CHEBI ID166852
SCHEMBL ID40282
MeSH IDM0115279

Synonyms (46)

Synonym
HMS1783G17
einecs 210-555-2
q4zcp9g95x ,
unii-q4zcp9g95x
nsc 74693
CHEBI:166852
m-iodobenzoic acid
benzoic acid, m-iodo-
nsc74693
nsc-74693
3-iodobenzoic acid
618-51-9
inchi=1/c7h5io2/c8-6-3-1-2-5(4-6)7(9)10/h1-4h,(h,9,10
benzoic acid, 3-iodo-
3-iodo-benzoic acid
3-iodobenzoic acid, 98%
NCIOPEN2_003856
CHEMBL67526
I0052
AKOS000119736
STK286092
AE-562/43403710
FT-0615895
AM20040868
AB01333667-02
meta-carboxy iodo-benzene
3-iodo benzoic acid
SCHEMBL40282
DTXSID6060682
W-105089
STR07725
PS-7510
AC-22932
mfcd00002496
CS-W009273
F2191-0117
3-iodobenzoic acid, purum, >=98.0% (hplc)
Z56924537
meta-iodobenzoic acid
SY001406
Q18472702
benzoic acid, 3-(iodocarbonyl)-
m-carboxyiodobenzene
EN300-17391
NCGC00341575-01
SB66453
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
iodobenzoic acidA member of the class of benzoic acids that is benzoic acid bearing at least one iodo substituent.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (11)

Assay IDTitleYearJournalArticle
AID1145614Dissociation constant, pKa of the compound1977Journal of medicinal chemistry, Jan, Volume: 20, Issue:1
Use of distribution coefficients in quantitative structure-activity relationships.
AID1145615Dissociation constant, pKa of the compound at pH 7.81977Journal of medicinal chemistry, Jan, Volume: 20, Issue:1
Use of distribution coefficients in quantitative structure-activity relationships.
AID226477Hammett constant was determined1993Journal of medicinal chemistry, Oct-01, Volume: 36, Issue:20
QSAR's from similarity matrices. Technique validation and application in the comparison of different similarity evaluation methods.
AID1145607Octanol-aqueous phase distribution coefficient, log D of the compound1977Journal of medicinal chemistry, Jan, Volume: 20, Issue:1
Use of distribution coefficients in quantitative structure-activity relationships.
AID28731Partition coefficient (logD2.0)1992Journal of medicinal chemistry, Sep-04, Volume: 35, Issue:18
Energy aspects of oil/water partition leading to the novel hydrophobic parameters for the analysis of quantitative structure-activity relationships.
AID1145605Octanol-water partition coefficient, log P of the compound1977Journal of medicinal chemistry, Jan, Volume: 20, Issue:1
Use of distribution coefficients in quantitative structure-activity relationships.
AID28497log (1/C') was determined1992Journal of medicinal chemistry, Sep-04, Volume: 35, Issue:18
Energy aspects of oil/water partition leading to the novel hydrophobic parameters for the analysis of quantitative structure-activity relationships.
AID226478Hammett constant was evaluated1996Journal of medicinal chemistry, May-24, Volume: 39, Issue:11
Comparative molecular moment analysis (CoMMA): 3D-QSAR without molecular superposition.
AID1145616Increase in membrane potential in mollusc neurons assessed as conductance of potassium at pH 7.8 relative to salicylic acid1977Journal of medicinal chemistry, Jan, Volume: 20, Issue:1
Use of distribution coefficients in quantitative structure-activity relationships.
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (33.33)18.7374
1990's3 (33.33)18.2507
2000's0 (0.00)29.6817
2010's3 (33.33)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 21.05

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index21.05 (24.57)
Research Supply Index2.40 (2.92)
Research Growth Index4.64 (4.65)
Search Engine Demand Index13.88 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (21.05)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]